Abstract
DNA Methyltransferase activity has been linked to the proliferation of breast cancers. Based on this, inhibiting DNMTs would be a strong preventative measure for cancer, as well as a possible treatment. Synthesizing drugs that can impede DNMTs is time-consuming and expensive to do in vitro and in vivo, so molecular biologists are resorting to in-silico methods of drug development. In-silico methods have been used to study DNMT inhibition, such as with compounds like ISL and RG108, as well as with large sets of thousands of compounds, as it saves time and money.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
